Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-11

FDA Approved: SILDENAFIL — Original Application (XLCARE Pharmaceuticals INC.)

View source ↗

Summary

FDA approved sildenafil as a generic drug under an Original Application (ANDA 202659) for XLCARE Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

ORIG AP for SILDENAFIL (SILDENAFIL)